FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1969707978> ?p ?o ?g. }

• W1969707978 endingPage "1286" @default.
• W1969707978 startingPage "1283" @default.
• W1969707978 abstract "Purpose We examined the rate of acute skin toxicity within a prospectively managed database of patients treated for early-stage non–small-cell lung cancer (NSCLC) and investigated factors that might predict skin toxicity. Methods From May 2006 through January 2008, 50 patients with Stage I NSCLC were treated at Memorial Sloan-Kettering Cancer Center with 60 Gy in three fractions or 44–48 Gy in four fractions. Patients were treated with multiple coplanar beams (3–7, median 4) with a 6 MV linac using intensity-modulated radiotherapy (IMRT) and dynamic multileaf collimation. Toxicity grading was performed and based on the National Cancer Institute Common Terminology Criteria for Adverse Effects. Factors associated with Grade 2 or higher acute skin reactions were calculated by Fisher's exact test. Results After a minimum 3 months of follow-up, 19 patients (38%) developed Grade 1, 4 patients (8%) Grade 2, 2 patients (4%) Grade 3, and 1 patient Grade 4 acute skin toxicity. Factors associated with Grade 2 or higher acute skin toxicity included using only 3 beams (p = 0.0007), distance from the tumor to the posterior chest wall skin of less than 5 cm (p = 0.006), and a maximum skin dose of 50% or higher of the prescribed dose (p = 0.02). Conclusions SBRT can be associated with significant skin toxicity. One must consider the skin dose when evaluating the treatment plan and consider the bolus effect of immobilization devices. We examined the rate of acute skin toxicity within a prospectively managed database of patients treated for early-stage non–small-cell lung cancer (NSCLC) and investigated factors that might predict skin toxicity. From May 2006 through January 2008, 50 patients with Stage I NSCLC were treated at Memorial Sloan-Kettering Cancer Center with 60 Gy in three fractions or 44–48 Gy in four fractions. Patients were treated with multiple coplanar beams (3–7, median 4) with a 6 MV linac using intensity-modulated radiotherapy (IMRT) and dynamic multileaf collimation. Toxicity grading was performed and based on the National Cancer Institute Common Terminology Criteria for Adverse Effects. Factors associated with Grade 2 or higher acute skin reactions were calculated by Fisher's exact test. After a minimum 3 months of follow-up, 19 patients (38%) developed Grade 1, 4 patients (8%) Grade 2, 2 patients (4%) Grade 3, and 1 patient Grade 4 acute skin toxicity. Factors associated with Grade 2 or higher acute skin toxicity included using only 3 beams (p = 0.0007), distance from the tumor to the posterior chest wall skin of less than 5 cm (p = 0.006), and a maximum skin dose of 50% or higher of the prescribed dose (p = 0.02). SBRT can be associated with significant skin toxicity. One must consider the skin dose when evaluating the treatment plan and consider the bolus effect of immobilization devices." @default.
• W1969707978 created "2016-06-24" @default.
• W1969707978 creator A5004459229 @default.
• W1969707978 creator A5010688246 @default.
• W1969707978 creator A5012978173 @default.
• W1969707978 creator A5015910445 @default.
• W1969707978 creator A5025513836 @default.
• W1969707978 creator A5049034607 @default.
• W1969707978 creator A5059651661 @default.
• W1969707978 creator A5069902321 @default.
• W1969707978 creator A5086286738 @default.
• W1969707978 date "2008-12-01" @default.
• W1969707978 modified "2023-09-26" @default.
• W1969707978 title "Acute Skin Toxicity Following Stereotactic Body Radiation Therapy for Stage I Non–Small-Cell Lung Cancer: Who's at Risk?" @default.
• W1969707978 cites W1985449980 @default.
• W1969707978 cites W2011762093 @default.
• W1969707978 cites W2013058506 @default.
• W1969707978 cites W2030326542 @default.
• W1969707978 cites W2046690397 @default.
• W1969707978 cites W2052345941 @default.
• W1969707978 cites W2068175268 @default.
• W1969707978 cites W2107814019 @default.
• W1969707978 cites W2126414636 @default.
• W1969707978 cites W2147544224 @default.
• W1969707978 cites W2159746573 @default.
• W1969707978 cites W2161400897 @default.
• W1969707978 doi "https://doi.org/10.1016/j.ijrobp.2008.08.036" @default.
• W1969707978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19028267" @default.
• W1969707978 hasPublicationYear "2008" @default.
• W1969707978 type Work @default.
• W1969707978 sameAs 1969707978 @default.
• W1969707978 citedByCount "162" @default.
• W1969707978 countsByYear W19697079782012 @default.
• W1969707978 countsByYear W19697079782013 @default.
• W1969707978 countsByYear W19697079782014 @default.
• W1969707978 countsByYear W19697079782015 @default.
• W1969707978 countsByYear W19697079782016 @default.
• W1969707978 countsByYear W19697079782017 @default.
• W1969707978 countsByYear W19697079782018 @default.
• W1969707978 countsByYear W19697079782019 @default.
• W1969707978 countsByYear W19697079782020 @default.
• W1969707978 countsByYear W19697079782021 @default.
• W1969707978 countsByYear W19697079782022 @default.
• W1969707978 countsByYear W19697079782023 @default.
• W1969707978 crossrefType "journal-article" @default.
• W1969707978 hasAuthorship W1969707978A5004459229 @default.
• W1969707978 hasAuthorship W1969707978A5010688246 @default.
• W1969707978 hasAuthorship W1969707978A5012978173 @default.
• W1969707978 hasAuthorship W1969707978A5015910445 @default.
• W1969707978 hasAuthorship W1969707978A5025513836 @default.
• W1969707978 hasAuthorship W1969707978A5049034607 @default.
• W1969707978 hasAuthorship W1969707978A5059651661 @default.
• W1969707978 hasAuthorship W1969707978A5069902321 @default.
• W1969707978 hasAuthorship W1969707978A5086286738 @default.
• W1969707978 hasConcept C116263406 @default.
• W1969707978 hasConcept C126322002 @default.
• W1969707978 hasConcept C126838900 @default.
• W1969707978 hasConcept C141071460 @default.
• W1969707978 hasConcept C2776256026 @default.
• W1969707978 hasConcept C2777793932 @default.
• W1969707978 hasConcept C2781047374 @default.
• W1969707978 hasConcept C29730261 @default.
• W1969707978 hasConcept C2989005 @default.
• W1969707978 hasConcept C509974204 @default.
• W1969707978 hasConcept C71924100 @default.
• W1969707978 hasConceptScore W1969707978C116263406 @default.
• W1969707978 hasConceptScore W1969707978C126322002 @default.
• W1969707978 hasConceptScore W1969707978C126838900 @default.
• W1969707978 hasConceptScore W1969707978C141071460 @default.
• W1969707978 hasConceptScore W1969707978C2776256026 @default.
• W1969707978 hasConceptScore W1969707978C2777793932 @default.
• W1969707978 hasConceptScore W1969707978C2781047374 @default.
• W1969707978 hasConceptScore W1969707978C29730261 @default.
• W1969707978 hasConceptScore W1969707978C2989005 @default.
• W1969707978 hasConceptScore W1969707978C509974204 @default.
• W1969707978 hasConceptScore W1969707978C71924100 @default.
• W1969707978 hasIssue "5" @default.
• W1969707978 hasLocation W19697079781 @default.
• W1969707978 hasLocation W19697079782 @default.
• W1969707978 hasOpenAccess W1969707978 @default.
• W1969707978 hasPrimaryLocation W19697079781 @default.
• W1969707978 hasRelatedWork W1977428742 @default.
• W1969707978 hasRelatedWork W1994364707 @default.
• W1969707978 hasRelatedWork W1994581662 @default.
• W1969707978 hasRelatedWork W2025704513 @default.
• W1969707978 hasRelatedWork W2044423573 @default.
• W1969707978 hasRelatedWork W2056468668 @default.
• W1969707978 hasRelatedWork W2626996138 @default.
• W1969707978 hasRelatedWork W3095751437 @default.
• W1969707978 hasRelatedWork W3157585601 @default.
• W1969707978 hasRelatedWork W320689403 @default.
• W1969707978 hasVolume "72" @default.
• W1969707978 isParatext "false" @default.
• W1969707978 isRetracted "false" @default.
• W1969707978 magId "1969707978" @default.
• W1969707978 workType "article" @default.